Apple Inc. vs 10x Genomics, Inc.
AAPL vs TXG — side-by-side comparison from reported financials. AAPL leads 5, TXG leads 2 of 7 comparable metrics.
Apple Inc.
AAPL · Technology
$336.11-1.27%Strong
10x Genomics, Inc.
TXG · Technology
$81.05+4.88%Strained
| Metric | AAPL | TXG |
|---|---|---|
| Price | $336.11 | $81.05 |
| Market cap | $4.91T | $10.6B |
| Revenue (TTM) | $467B | $617M |
| Revenue growth | +1.8% | +7.6% |
| Net margin | 27.6% | -12.2% |
| Free cash flow | $137B | $121M |
| Net cash (debt) | ($31.6B) | — |
| 1-year price return | +32.3% | +592.1% |
| P/E | 38.1 | — |
| P/E vs own history (cheap-side %) | 7% | — |
| Dividend yield | 0.32% | — |
| Return on equity | 137% | -9% |
| Altman Z-score | 12.84 | — |
| CV checks passed | 11 of 11 | 4 of 11 |
| Employees | 166,000 | 1,178 |
Full résumé-style profiles: AAPL CV · TXG CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.